Physician profile
Jim Youssef
NPI 1154373850
$2,297,575.56
in general payments reported to CMS, 2019-2025
14 companies · $25K in 2025
The $25K reported for 2025 was more than what 80% of Orthopaedic Surgery of The Spine providers received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1.1M · 2020: $324K · 2021: $310K · 2022: $359K · 2023: $168K · 2024: $25K · 2025: $25K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $127K · Royalty Or License: $81K · Travel and Lodging: $7,633 · Food and Beverage: $1,419.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $126,747.06 |
| Royalty Or License | $81,253.62 |
| Travel and Lodging | $7,632.53 |
| Food and Beverage | $1,418.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuvasive, INC. | $2,094,531.57 | 2019-2023 | Xlif, Reline |
| Mml US, INC. | $62,492.25 | 2022-2024 | Reactiv8 |
| Ctl Medical Corporation | $51,929.04 | 2019-2024 | Spinal |
| Globus Medical, INC. | $48,393.73 | 2019-2025 | Reline, Creo 5.5 |
| Seaspine Orthopedics Corporation | $36,938.91 | 2019-2022 | |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $1,150.00 | 2021 | |
| Providence Medical Technology, INC. | $916.66 | 2019 | |
| Orthofix Medical, INC. | $665.89 | 2023-2025 | Sonoma, Firebird Si Navigation System |
| Augmedics INC. | $220.42 | 2020-2024 | Xvision |
| Medical Device Business Services, INC. | $124.04 | 2025 | Vivigen Mis Delivery System |
| Zimmer Biomet Holdings, INC. | $97.38 | 2019 | |
| Curiteva, INC. | $93.16 | 2024 | |
| Kuros Biosciences USA, INC | $22.51 | 2024 | Magnetos |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$2,304,979.60 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jim Youssef listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.